Furthermore, YKL-40 levels reliably predicted recurrent and advanced ovarian cancer in these study cohorts since increased levels were observed during advancement of disease [139] indicating that YKL-40 may represent a potential biomarker for early detection of ovarian cancer. The gene discussed is CHI3L1; the disease is ovarian cancer.